Brokers expect National Health Investors, Inc. (NYSE:NHI) to post earnings of $1.20 per share

Equity research analysts expect National Health Investors, Inc. (NYSE:NHI – Get a rating) to report earnings of $1.20 per share for the current quarter, according to Zacks. Two analysts made National Health Investors earnings estimates. The lowest EPS estimate is $1.18 and the highest is $1.21. National Health Investors posted earnings per share of $1.16 in the same quarter last year, suggesting a positive year-over-year growth rate of 3.4%. The company is due to announce its next earnings report on Monday, January 1.

On average, analysts expect National Health Investors to report annual earnings of $4.50 per share for the current fiscal year, with EPS estimates ranging from $4.43 to $4.59. For the next fiscal year, analysts expect the company to post earnings of $4.59 per share, with EPS estimates ranging from $4.52 to $4.66. Zacks Investment Research’s EPS calculations are an average based on a survey of research firms that provide coverage for domestic healthcare investors.

National Health Investors (NYSE: NHI – Get a rating) last released its quarterly earnings data on Monday, May 9. The real estate investment trust reported EPS of $0.18 for the quarter, missing analyst consensus estimates of $0.63 per ($0.45). National Health Investors posted a net margin of 29.35% and a return on equity of 5.55%. The company posted revenue of $71.33 million for the quarter, versus analyst estimates of $73.06 million. During the same period a year earlier, the company posted EPS of $1.24. The company’s revenue was down 11.8% year over year.

A number of analysts have commented on the company. Zacks Investment Research moved National Health Investors from a “strong sell” rating to a “hold” rating in a Friday, May 13 research report. Credit Suisse Group began covering National Health Investors in a research report on Tuesday, February 1. They set an “underperforming” rating and a target price of $51.00 for the company. BMO Capital Markets cut its price target on National Health Investors from $63.00 to $61.00 and set an “outperform” rating for the company in a Tuesday, April 19 research report. To finish, StockNews.com began covering domestic healthcare investors in a research report on Thursday, March 31. They set a “hold” rating for the company. One financial analyst has assigned the stock a sell rating, four have issued a hold rating and two have assigned the company a buy rating. Based on data from MarketBeat.com, National Health Investors has a consensus rating of “Hold” and a consensus target price of $62.00.

NHI shares opened at $58.92 on Friday. The stock has a 50-day moving average of $55.85 and a two-hundred-day moving average of $56.10. The company has a current ratio of 23.40, a quick ratio of 23.40 and a debt ratio of 0.84. National Health Investors has a 12-month low of $50.22 and a 12-month high of $69.23. The company has a market capitalization of $2.70 billion, a P/E ratio of 32.02 and a beta of 0.97.

The company also recently announced a quarterly dividend, which will be paid on Friday, August 5. Investors of record on Thursday, June 30 will receive a dividend of $0.90 per share. The ex-date of this dividend is Wednesday, June 29. This represents an annualized dividend of $3.60 and a dividend yield of 6.11%. National Health Investors’ dividend payout ratio (DPR) is currently 195.65%.

Hedge funds have recently increased or reduced their holdings in the stock. Marshall Wace North America LP acquired a new stake in National Health Investors during Q1 worth $31,000. Covestor Ltd acquired a new stake in National Health Investors during the 4th quarter worth $33,000. TCI Wealth Advisors Inc. increased its stake in National Health Investors by 566.0% during the 1st quarter. TCI Wealth Advisors Inc. now owns 706 shares of the real estate investment trust worth $42,000 after buying an additional 600 shares in the last quarter. Wealth Quarterback LLC increased its stake in National Health Investors stock by 427.1% in Q3. Wealth Quarterback LLC now owns 4,544 shares of the real estate investment trust valued at $44,000 after purchasing 3,682 additional shares during the period. Finally, Mitsubishi UFJ Trust & Banking Corp increased its stake in National Health Investors shares by 232.1% in the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 1,003 shares of the real estate investment trust valued at $57,000 after buying an additional 701 shares during the period. 63.53% of the shares are held by hedge funds and other institutional investors.

About National Health Investors (Get a rating)

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in the sale-leaseback, joint venture, mortgage and mezzanine financing of seniors’ housing and medical investments based on need and discretionary. NHI’s portfolio includes independent, assisted living and memory care communities, fee-paying retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Recommended Stories

Get a Free Copy of Zacks National Health Investors (NHI) Research Report

For more information on Zacks Investment Research’s research offerings, visit Zacks.com

History and Earnings Estimates for Domestic Healthcare Investors (NYSE: NHI)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in National Health Investors right now?

Before you consider National Health Investors, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and National Health Investors was not on the list.

While National Health Investors currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here